Drug-Free Communities Mentoring Program

SP-16-002WT_DrugFree
Drug-Free Communities Mentoring Program
Department of Health and Human Services
Substance Abuse and Mental Health Services Admin

The Drug-Free Communities (DFC) Support Program was created by the Drug-Free Communities (DFC) Act of 1997 (Public Law 105-20). DFC Mentoring grants were established as a component of the DFC Support Program when the program was reauthorized in 2001 (Public Law 107-82, 115 Stat. 814). The DFC Mentoring Program was also included in the Office of National Drug Control Policy Reauthorization Act of 2006 (Public Law 109-469).

The primary goal of the DFC Mentoring Program is to assist newly forming coalitions in becoming eligible to apply for DFC funding on their own.

It is the intent of the DFC Mentoring Program that, at the end of the Mentoring grant, each Mentee coalition will meet all of the Statutory Eligibility Requirements of the DFC Support Program and be fully prepared to compete for the DFC grant on their own. Grantees will be expected to achieve this goal by meeting the following objectives:

  1. Strengthen Mentee coalition’s organizational structure.
  2. Increase Mentee coalition’s leadership and community readiness to address youth substance use problems in the Mentee community.
  3. Assist the Mentee coalition in working through a strategic planning process that will result in a comprehensive Action Plan.

General Information

Document Type: Grants Notice
Funding Opportunity Number: SP-16-002
Funding Opportunity Title: Drug-Free Communities Mentoring Program
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 10
CFDA Number(s): 93.276 — Drug-Free Communities Support Program Grants
Cost Sharing or Matching Requirement: Yes
Posted Date: Mar 10, 2016
Last Updated Date: Mar 10, 2016
Original Closing Date for Applications: May 16, 2016  
Current Closing Date for Applications: May 16, 2016  
Archive Date: Jun 15, 2016
Estimated Total Program Funding: $750,000
Award Ceiling: $75,000
Award Floor: $0

Eligibility

Eligible Applicants:
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible applicants are currently funding DFC grantees with a coalition that has been in existence for at least five years (not to be interpreted as having been a DFC grant for five years); has an active DFC grant at the time of application; and, is in good standing (not on high risk.)

Additional Information

Agency Name: Substance Abuse and Mental Health Services Admin
Description: The Drug-Free Communities (DFC) Support Program was created by the Drug-Free Communities (DFC) Act of 1997 (Public Law 105-20). DFC Mentoring grants were established as a component of the DFC Support Program when the program was reauthorized in 2001 (Public Law 107-82, 115 Stat. 814). The DFC Mentoring Program was also included in the Office of National Drug Control Policy Reauthorization Act of 2006 (Public Law 109-469). The primary goal of the DFC Mentoring Program is to assist newly forming coalitions in becoming eligible to apply for DFC funding on their own. It is the intent of the DFC Mentoring Program that, at the end of the Mentoring grant, each Mentee coalition will meet all of the Statutory Eligibility Requirements of the DFC Support Program and be fully prepared to compete for the DFC grant on their own. Grantees will be expected to achieve this goal by meeting the following objectives: 1. Strengthen Mentee coalition’s organizational structure. 2. Increase Mentee coalition’s leadership and community readiness to address youth substance use problems in the Mentee community. 3. Assist the Mentee coalition in working through a strategic planning process that will result in a comprehensive Action Plan.
Link to Additional Information: Drug-Free Communities Mentoring Program
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Jennifer Cramer, Office of Financial Resources, Division of Grants Management, SAMHSA Rockville, MD 20857 Phone: (240) 276-1400
DGM@samhsa.hhs.gov

Advertisements

Children with Special Health Care Needs (CSHCN) Transition Family Tool

Children with Special Health Care Needs (CSHCN) Transition Family Tool

csnch
SOURCE: Texas Health and Human Services Commission (HHSC), Texas Department of State Health Services (DSHS)
APPLICATION DEADLINE: 11/19/15.
$ AVAILABLE: The total amount of the contract that results from this RFP is for $300,000 with no more than $100,000 available for each state fiscal year throughout the term of the contract.
ELIGIBILITY: Please see URL for complete eligibility requirements.
PURPOSE: The Texas Health and Human Services Commission (HHSC) on behalf of the Department of State Health Services (DSHS) (HHSC), seeks one qualified vendor to contract with the Children with Special Health Care Needs (CSHCN) Services Program at the Department of State Health Services (DSHS) to develop a family tool to improve transition outcomes for Children and Youth with Special Health Care Needs (CYSHCN) in accordance with the specifications contained in the Request for Proposals (RFP).
CFDA: none
CONTACT: Donna Ockletree, (512) 406-2531, email: Donna.Ockletree@hhsc.state.tx.us. For more information seehttp://esbd.cpa.state.tx.us/bid_show.cfm?bidid=120926
From HHSC Procurement and Contracting Services email, 10/29/15icon
Subject(s) children’s health, health care services

PRIVATE FOA: AONE Foundation for Nursing Leadership and Education Accepting Applications for Small Grants

AONE Foundation for Nursing Leadership and Education Accepting Applications for Small Grants

Portrait of a doctor with two of her co-workers talking with a patient in the background

SOURCE: AONE Foundation for Nursing Leadership and Education
APPLICATION DEADLINE: 12/31/15.
$ AVAILABLE: In 2016, grants of up to $10,000 will be awarded in support of projects that advance innovation as a core competency for all nurse leaders; promote community-based teams across the care continuum; encourage provision of safe, quality care in delivery systems grounded in healthful practice environments; and improve communication of the value of nursing in healthcare to all stakeholders.
ELIGIBILITY: AONE members and nonmembers alike are eligible.
PURPOSE: The AONE Foundation for Nursing Leadership Research and Education was established in 2010 to support the research and educational priorities of the American Organization of Nurse Executives, a national membership organization for nurses who design, facilitate, and manage care. Since 1967, AONE has provided leadership, professional development, advocacy, and research to advance nursing practice and patient care, promote nursing leadership excellence, and to shape public policy for health care.
The foundation is accepting applications for its Small Grants Program, which supports research projects that align with its research priorities.
CONTACT: M.T. Meadows, (312) 422-2807, email: mmeadows@aha.org.

For more information see http://www.aone.org/aone_foundation/smallgrants.shtml
From The Foundation Center’s Philanthropy News Digest web site, accessed 10/22/15icon
Subject(s) medical research, nursing

PRIVATE FOA: American Heart Association Hypertension Control Grants

American Heart Association Hypertension Control Grantshypertension
SOURCE: American Heart Association (AHA) SouthWest Affiliate
APPLICATION DEADLINE: 11/3/15 at 4 pm CST.
$ AVAILABLE: The maximum amount for an individual grant is $100,000.
ELIGIBILITY: Nonprofit healthcare entities in Arkansas, Colorado, New Mexico, Oklahoma, Texas, and Wyoming.
PURPOSE: There are 80 million adults (1 in 3 Americans) living with high blood pressure. Despite improved access to care, effective therapies, and proven lifestyle interventions, achieving success in hypertension control remains an increasing challenge. Nearly 46 percent (36.7 million) of adults with high blood pressure are not controlled to goal. In November 2013, the AHA, American College of Cardiology and Centers for Disease Control jointly published a new science advisory that urged doctors, other healthcare providers and hospitals to collaborate on programs that help patients control high blood pressure.
AHA set forth an aggressive goal to move 13.6 million Americans to control their high blood pressure by 2020. The Board of Directors for the SouthWest Affiliate has made hypertension control a priority and is demonstrating its commitment by making $500,000 available in funding.
This RFP [Request for proposals] serves as a catalyst for institutions to make hypertension a priority by adopting guidelines and a team-base care approach to improve performance measures around hypertension management. The target goal for this request for proposal is for the healthcare systems to drive a minimum hypertension control rate of 70 percent and the healthcare system which achieves the highest control rate will receive an additional $10,000 bonus award.
CONTACT: Brion Oaks, (512) 338-2478, email: brion.oaks@heart.org.

Go to: https://www.surveymonkey.com/r/CheckChangeControl for the on-line application.
From American Heart Association SouthWest Affiliate email, 10/21/15icon
Subject(s) cardiovascular/heart disease, medical research

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01): RFA-FD-15-001
SOURCE: U.S. Food and Drug Administration (FDA), Office of Orphan Products Development (OPD)
APPLICATION DEADLINE: 2/3/16, 2/1/17, 2/7/18.
$ AVAILABLE: $14.1 million in FY2016, FY2017, FY2018, and FY2019.

orphan-drugs-acts-past-and-current-scenario-with-upcoming-drugs-20-638
Background

The OPD was created to identify and promote the development of orphan products. Orphan products are drugs, biologics, medical devices, and medical foods that are indicated for a rare disease or condition. The term “rare disease or condition” is defined in 21 U.S.C. 360ee.  As a practical way to implement the statutory definition, for devices and foods as well as for drugs, FDA considers drugs, devices, and medical foods potentially eligible for grants under the OPD grant program if they are indicated for a disease or condition that has a prevalence, not incidence, of fewer than 200,000 people in the United States. Diagnostics and vaccines are considered potentially eligible for such grants only if the U.S. population to whom they will be administered is fewer than 200,000 people in the United States per year.

Research Objectives

The goal of FDA’s OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application’s Background and Significance section documentation to support that the estimated prevalence of the orphan disease or condition in the United States is less than 200,000 (or in the case of a vaccine or diagnostic, information to support that the product will be administered to fewer than 200,000 people in the United States per year),and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.  Additional information may be required upon request, for example, regarding population estimate and rationale.  This additional information may be required, in part, to assure that human clinical trials of drugs are eligible to receive funding under the OPD grant program.  21 U.S.C. 360ee(b)(1)(A).See Section VIII, Other Information – Required Federal Citations, for policies related to this announcement.

– See more at: http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-15-001.html#sthash.KSPsucAw.dpuf
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
PURPOSE: The goal of FDA’s OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the existing therapy.
CFDA: 93.103
CONTACT: Please see URL for multiple contacts.

For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-15-001.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 10/21/15icon
Subject(s) medical research, minority health

Supporting the National Blood Transfusion Service (NBTS) in the implementation and expansion of Blood Safety activities in the Republic of Zambia under the President’s Emergency plan for AIDS Relief (PEPFAR)

CDC-RFA-GH16-1709
Supporting the National Blood Transfusion Service (NBTS) in the implementation and expansion of Blood Safety activities in the Republic of Zambia under the President’s Emergency plan for AIDS Relief (PEPFAR)
Department of Health and Human ServicesSHARMAINE-Byrne-Mwenda-blood-donor-donation-ZNBTS-Joseph-Mulenga
Centers for Disease Control and Prevention

FOA Summary

The purpose of this FOA is to support the Zambia National Blood Transfusion Service (NBTS) in the provision of safe and adequate supply of blood and blood products to health facilities in Zambia. This support will cover a one year period as the institution transitions to full host government support. In particular, the funding will support activities to improve blood donations from repeat, regular voluntary non-remunerated donors (VNRD); to ensure safety through a centralized testing system by the Zambia National Blood Transfusion Services; and to promote appropriate use of blood and blood components. It will also link with other HIV prevention activities through integration of prevention education in youth and adult donor recruitment and in notification of donor test results with appropriate referral to care and treatment services. The NBTS will also support, coordinate and guide the activities of all other partners involved in mobilization and retention of volunteer blood donors.
The ZNBTS will work in collaboration with the HHS/CDC Zambia office and the Zambian MOH, to achieve program outcomes. All activities implemented under this program should follow national policies and guidelines for the delivery of Blood Safety interventions. The recipient will work in collaboration with the Zambian MOH, the U.S. Government in-country Emergency Plan team, and the HHS/CDC Zambia office to improve the breadth, scale, and quality of the Blood Safety program (including mobilization of low-risk, voluntary non-remuneratedblood donors, blood collection, transport through the cold chain, testing for transfusion transmissible infections (HIV, HBV, HCV, syphilis) at quality assured laboratories, establishment of national quality system, including guidelines, standard operating procedures, accurate records, monitoring and evaluation, distribution of blood and blood products to the health facilities, coordinate and monitor the appropriate clinical use of blood and outcomes of transfusion (hemovigilance) and the establishment of a comprehensive quality system covering the entire transfusion process, from donor recruitment to the follow-up of recipients of transfusion).
The emphasis is to have quality systems in place while at the same time implementing evidence based strategies and improving on program management and evaluation (M&E). Since children below five years and women of reproductive age receive approximately two thirds of the national blood collections, the preparation of pediatric blood packs will be a significant component of blood safety activities.
In addition to program implementation, ZNBTS should continue to develop methods to create and build the capacity of its own and other organizations responsible for blood safety and transfusion services.
The ZNBTS will seek to obtain final government commitment for its own support and recognition as a separate unit with an adequate budget, necessary legislation/regulation, management team, and the formation of an organization with responsibility and authority for the ZNBTS. Additionally, the ZNBTS will foster development and implementation of a budgeting and finance system to ensure a sustainable blood program through cost recovery and/or annual budget allocation.
The ZNBTS must promote sustainability with continued, high-quality and evidence based interventions through local and indigenous organizations in collaboration with the Zambian MOH. In particular it should build the local indigenous capacity to be able to carry out various blood safety related interventions. NBTS will demonstrate increased financial support of blood transfusion services and this should be evident though increased donor mobilization, continued staff training and improved high-quality testing and processing of blood.
The ZNBTS will work with other Emergency Plan partners if necessary to evaluate and explore donor recruitment and cost effective strategies.
To avoid the overdependence on a sole donor, the recipient will be expected to diversify the funding base by applying and managing additional grants from other international development and funding agencies.
The overall outcome is to increase the supply of safe blood for transfusion to sufficient levels in the next one year to prevent biomedical transmission of HIV (and other transfusion transmissible infections [TTIs]).

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH16-1709
Funding Opportunity Title: Supporting the National Blood Transfusion Service (NBTS) in the implementation and expansion of Blood Safety activities in the Republic of Zambia under the President’s Emergency plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
CFDA Number(s): 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Posted Date: Oct 26, 2015
Creation Date: Oct 26, 2015
Original Closing Date for Applications: Dec 26, 2015  
Current Closing Date for Applications: Dec 26, 2015  
Archive Date: Jan 25, 2016
Estimated Total Program Funding:
Award Ceiling: $1,353,644
Award Floor: $0

Eligibility

Eligible Applicants:
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Zambia National Blood Transfusion Service (ZNBTS)

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: To ensure adequacy and equitable access to cost effective and affordable safe blood and blood products throughout the country, in accordance with the set goals, objectives and targets, CDC intends through this FOA to provide funding support to the Government mandated institution to collect, screen, and distribute blood and blood products to health facilities; with the ultimate goals of reducing child mortality, improving maternal health and combating HIV/AIDS, malaria and other diseases.
Link to Additional Information:  http://www.grants.gov/web/grants/view-opportunity.html?oppId=279838
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Technical Information Management Section Department of Health and Human Services CDC Procurement and Grants Office 2920 Brandywine Road, MS E-14 Atlanta, GA 30341 Telephone: 770-488-2700
pgotim@cdc.gov

For more grant funding opportunities like this one please see:

http://www.grants.gov/web/grants/view-opportunity.html?oppId=279839

http://www.grants.gov/web/grants/view-opportunity.html?oppId=279840

http://www.grants.gov/web/grants/view-opportunity.html?oppId=279841

HRSA-16-074 Substance Abuse Service Expansion

HRSA-16-074
Substance Abuse Service Expansion
Department of Health and Human Services
Health Resources and Services Administration

General Information

Document Type: Grants Notice
Funding Opportunity Number: HRSA-16-074
Funding Opportunity Title: Substance Abuse Service Expansion
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation: https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=5eb8b6e3-6c30-4162-80f9-68fd9d0f56df
Expected Number of Awards: 310
CFDA Number(s): 93.527 — Affordable Care Act (ACA) Grants for New and Expanded Services under the Health Center Program
Cost Sharing or Matching Requirement: No
Posted Date: Jul 30, 2015
Creation Date: Jul 30, 2015
Original Closing Date for Applications: Sep 28, 2015  
Current Closing Date for Applications: Sep 28, 2015  
Archive Date: Nov 27, 2015
Estimated Total Program Funding: $100,000,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants:
Private institutions of higher education
Public and State controlled institutions of higher education
Independent school districts
Special district governments
County governments
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Eligible applicants must be an existing Health Center Program award recipient funded under section 330(e), (g), (h) and/or (i) of the Public Health Service Act that did not receive initial Health Center Program funding as a new start/new award recipient in FY 2015 (via a New Access Point, Service Area Competition, or Service Area Competition – Additional Area grant award).

Additional Information

Agency Name: Health Resources and Services Administration
Description: This announcement solicits applications for Fiscal Year (FY) 2016 Substance Abuse Service Expansion. The purpose of this Health Center Program supplemental funding opportunity is to improve and expand the delivery of substance abuse services at existing health centers, 1 with a focus on Medication-assisted Treatment (MAT) in opioid use disorders